Financial Daily from THE HINDU group of publications
Friday, May 31, 2002
Financial Daily from THE HINDU group of publications Friday, May 31, 2002 |
|
|
|
|
|
Corporate
-
IPR Dr Reddy's files patent application in US Our Bureau
HYDERABAD, May 30 DR Reddy's Laboratories has stated that it had filed an Abbreviated New Drug Application (ANDA) with the US Food and Drug Administration for `clopidogrel bisulfate' (CB) 75 mg tablets with Para IV certification on all listed Orange Book patents. In a press release here on Thursday, Dr Reddy's also cited that it had notified Sanofi-Synthelabo Inc, upon which the latter had filed a lawsuit against the company alleging patent infringement. CB is the generic version of Sanofi-Synthelabo's Plavix. CB is indicated for the reduction of atherosclerotic events (mycordial infraction, stroke and vascular death) in patients. The product had US brand sales of $1.1 billion during 2001 with an estimated annual growth rate of 52 per cent.
Send this article to Friends by E-Mail
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | Home |
Copyright © 2002, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|